UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?

European heart journal, 2012-05, Vol.33 (9), p.1049-1057

2012

Volltextzugriff (PDF)

Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval

Clinical pharmacology and therapeutics, 2012-03, Vol.91 (3), p.426-437

2012

Volltextzugriff (PDF)

What are the main environmental factors driving the development of the neurotoxic dinoflagellate Vulcanodinium rugosum in a Mediterranean ecosystem (Ingril lagoon, France)?

Harmful algae, 2018-05, Vol.75, p.75-86

2018

Volltextzugriff (PDF)

Rosiglitazone: a European regulatory perspective

Diabetologia, 2011-02, Vol.54 (2), p.213-218

2011

Volltextzugriff (PDF)

Response of diatom and dinoflagellate lifeforms to reduced phosphorus loading: A case study in the Thau lagoon, France

Estuarine, coastal and shelf science, 2015-09, Vol.162, p.45-52

2015

Volltextzugriff (PDF)

Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies

Annals of the Rheumatic Diseases, 2011-10, Vol.70 (10), p.1713-1718

2011

Volltextzugriff (PDF)

need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)

Osteoporosis international, 2010-05, Vol.21 (5), p.713-722

2010

Volltextzugriff (PDF)

10. Extended evaluation of mixed-mode and lipophilic sorbents for passive sampling of marine toxins

Toxicon (Oxford), 2014-12, Vol.91, p.168-169

2014

Volltextzugriff (PDF)

Variation in Health Technology Assessment and Reimbursement Processes in Europe

Value in health, 2017-01, Vol.20 (1), p.67-76

2017

Volltextzugriff (PDF)

Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis

Osteoarthritis and cartilage, 2005, Vol.13 (1), p.13-19

2005

Volltextzugriff (PDF)

Cellular models and cytotoxicity of pinnatoxin-G and extracts of the dinoflagellate Vulcanodinium rugosum recently isolated from the French mediterranean lagoon of Ingril

Toxicon (Oxford), 2013-12, Vol.75, p.215-216

2013

Volltextzugriff (PDF)

Metabolic Syndrome, New Onset Diabetes, and New End points in Cardiovascular Trials

Journal of cardiovascular pharmacology, 2006-03, Vol.47 (3), p.469-475

2006

Volltextzugriff (PDF)

Renal Fanconi syndrome with meropenem/amoxicillin-clavulanate during treatment of extensively drug-resistant tuberculosis

The European respiratory journal, 2017-12, Vol.50 (6), p.1702023-1702023

2017

Volltextzugriff (PDF)

Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers

Nature reviews. Drug discovery, 2010-04, Vol.9 (4), p.277-291

2010

Volltextzugriff (PDF)

European regulatory perspectives for innovative therapies

Osteoporosis international, 2008-06, Vol.19 (6), p.725-731

2008

Volltextzugriff (PDF)

Recurrent Selection for Partial Resistance to Crown Rust in Oat

Crop science, 2002-09, Vol.42 (5), p.1475-1482

2002

Volltextzugriff (PDF)

Oligotrophication and emergence of picocyanobacteria and a toxic dinoflagellate in Thau lagoon, southern France

Journal of sea research, 2009, Vol.61 (1), p.68-75

2009

Volltextzugriff (PDF)

A comparative analysis of Alexandrium catenella/tamarense blooms in Annaba Bay (Algeria) and Thau lagoon (France); phosphorus limitation as a trigger

Comptes rendus. Biologies, 2014-02, Vol.337 (2), p.117-122

2014

Volltextzugriff (PDF)

Biomarkers for Alzheimer's disease therapeutic trials

Progress in neurobiology, 2011-12, Vol.95 (4), p.579

2011

Volltextzugriff (PDF)

Background for studies on the treatment of male osteoporosis: state of the art

Annals of the rheumatic diseases, 2000-10, Vol.59 (10), p.765-772

2000

Volltextzugriff (PDF)

Uncertain future of trials in osteoporosis

Osteoporosis international, 2002-01, Vol.13 (6), p.443-449

2002

Volltextzugriff (PDF)

Report on the first detection of pectenotoxin-2, spirolide-a and their derivatives in French shellfish

Marine drugs, 2007-11, Vol.5 (4), p.168-179

2007

Volltextzugriff (PDF)

The use of placebo-controlled and non-inferiority trials for the evaluation of new drugs in the treatment of postmenopausal osteoporosis

Osteoporosis international, 2002-01, Vol.13 (1), p.1-5

2002

Volltextzugriff (PDF)

Study Design in Osteoporosis: A European Perspective

Journal of bone and mineral research, 2003-06, Vol.18 (6), p.1133-1138

2003

Volltextzugriff (PDF)

Endpoints for trials in Alzheimer's disease: a European task force consensus

Lancet neurology, 2008-05, Vol.7 (5), p.436-450

2008

Volltextzugriff (PDF)

1 – 25 von 588

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(472)
Mit Volltextzugriff
(475)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(252)
Life Sciences & Biomedicine
(179)
Humans
(166)
Female
(96)
Male
(78)
Biological And Medical Sciences
(75)
Adult
(58)
Medical Sciences
(54)
Physical Sciences
(49)
Middle Aged
(44)
Animals
(42)
Aged
(41)
Life Sciences
(37)
Physics
(36)
Technology
(32)
Fundamental And Applied Biological Sciences. Psychology
(25)
Astronomy & Astrophysics
(24)
General & Internal Medicine
(24)
Astrophysics
(23)
Treatment Outcome
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Diabetes clinical trials: helped or hindered by the current shift in regulatory requirements?

Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval

What are the main environmental factors driving the development of the neurotoxic dinoflagellate Vulcanodinium rugosum in a Mediterranean ecosystem (Ingril lagoon, France)?

Rosiglitazone: a European regulatory perspective

Response of diatom and dinoflagellate lifeforms to reduced phosphorus loading: A case study in the Thau lagoon, France

Biomarkers and personalised medicine in rheumatoid arthritis: a proposal for interactions between academia, industry and regulatory bodies

need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)

10. Extended evaluation of mixed-mode and lipophilic sorbents for passive sampling of marine toxins

Variation in Health Technology Assessment and Reimbursement Processes in Europe

Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis

Cellular models and cytotoxicity of pinnatoxin-G and extracts of the dinoflagellate Vulcanodinium rugosum recently isolated from the French mediterranean lagoon of Ingril

Metabolic Syndrome, New Onset Diabetes, and New End points in Cardiovascular Trials

Renal Fanconi syndrome with meropenem/amoxicillin-clavulanate during treatment of extensively drug-resistant tuberculosis

Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers

European regulatory perspectives for innovative therapies

Recurrent Selection for Partial Resistance to Crown Rust in Oat

Oligotrophication and emergence of picocyanobacteria and a toxic dinoflagellate in Thau lagoon, southern France

A comparative analysis of Alexandrium catenella/tamarense blooms in Annaba Bay (Algeria) and Thau lagoon (France); phosphorus limitation as a trigger

Biomarkers for Alzheimer's disease therapeutic trials

Background for studies on the treatment of male osteoporosis: state of the art

Uncertain future of trials in osteoporosis

Report on the first detection of pectenotoxin-2, spirolide-a and their derivatives in French shellfish

The use of placebo-controlled and non-inferiority trials for the evaluation of new drugs in the treatment of postmenopausal osteoporosis

Study Design in Osteoporosis: A European Perspective

Endpoints for trials in Alzheimer's disease: a European task force consensus

Suchergebnisse filtern